Antibiotic resistance rates of Shigella species isolated from stool cultures in the years 1999-2003;Dιşkι kültürlerinden 1999-2003 yιllarι arasιnda izole edilen Shigella türleri ve antibiyotiklere direnç oranlarι

Mikrobiyoloji Bulteni

Volumn 40, Issue 1-2, 2006, Pages 9-14

  Alici, Özlem ^a   Açikgöz, Z Cibali ^b   Gamberzade, Şöhret ^c   Göçer, Safiye ^d   Karahocagil, M Kasim ^e  

^a FATIH UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Akay Hastanesi   (Turkey)

^d Lokman Hekim Private Hospital   (Turkey)

^e MINISTRY OF HEALTH   (Turkey)

Author keywords

Antibiotic resistance; Shigella; Stool cultures

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CIPROFLOXACIN; COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENZYMOLOGY; FECES; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; SEASON; SHIGELLA;

AMPICILLIN; ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FECES; HUMANS; SEASONS; SHIGELLA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 39049181443     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Niyogi SK. Shigellosis. J Microbiol 2005; 41 133-43.
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. 20th Informational Supplement. Approved Standard M100-S12. 2002, NCCLS, Wayne, PA.
3. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
4. Chu YW, Houang ETS, Lyon DJ, Ling JM, Ng TK, Cheng AF. Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995. Antimicrob Agents Chemother 1998; 42: 440-3.
5. Ergonul O, Imre A, Celikbas A, Dokuzoguz B. Drug resistance of Shigella species: changes over 20 years in Turkey. Int J Antimicrob Agents 2004; 23: 527-8.
6. Ozmert EN, Gokturk B, Yurdakok K, Yalçin SS, Gur D. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002. J Pediatr Gastroenterol Nutr 2005; 40: 359-62.
7. Yurdakok K, Sahin N, Ozmert E, Berkman E. Shigella gastroenteritis: clinical and epidemiological aspects, and antibiotic susceptibility. Acta Paediatr Jpn 1997; 39: 681-4.
8. Aysev AD, Guriz H. Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993-1996. Scand J Infect Dis 1998; 30: 351-3.
9. Chompook P, Samosornsuk S, Von Seidlein L, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 2005; 83: 739-46.
10. Agtini MD, Soeharno R, Lesmana M, et al. The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis 2005; 5: 89.
11. Nguyen TV, Le PV, Le CH, Weintraub A. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Wietnam. Antimicrob Agents Chemother 2005; 49: 816-9.
12. Fulla N, Prado V, Duran C, Lagos R, Levine MM. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg 2005; 72: 851-4.
13. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. Outbreak of dysentery associated with ceftriaxone resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type Amp C beta lactamase resistance in S.sonnei. J Clin Microbiol 2005; 43: 2608-12.
14. Turkmen A, Erbay A, Yeter T, Esener H, Dokuzoguz B. Shigellozis olgulan: epidemiyolojik özellikleri ve direnç sorunu. Ankem Derg 1999; 13: 139.
15. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended spectrum beta lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2003; 35: 503-5.
16. Chehung TKM, Chu YW, Tsang GKL, Ngan JYW, Hui ISC, Kam KM. Emergence of CTX-M-type B lactam resistance in Shigella spp in Hong Kong. Int J Antimicrob Agents 2005; 25: 350-3.